India Cell & Gene Therapy Business Report 2023 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering.

This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry.

It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product.

Reasons to buy

• In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in India.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the India.

Cell & Gene Therapy Market Size by Product

• Abecma
• Amondys
• Breyanzi
• Carvykti
• Givlaari
• Kimmtrak
• Kymriah
• Leqvio
• Luxturna
• Onpattro
• Oxlumo
• Rethymic
• Skysona
• Stratagraft
• Tecartus
• Tegsedi
• Viltepso
• Vyondys
• Yescarta
• Zolgensma
• Zynteglo

Key Topics Covered:

1 India Cell and Gene Therapy Market Size and Forecast, 2018-2027

2 India Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027

2.1 India Market Size by Cell and Gene Modified Cell Therapies, 2018-2027

2.2 India Market Size by Gene Therapy and Genome Therapy, 2018-2027

2.3 India Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027

3 India Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027

3.1 India Cell and Gene Therapy Market Size by Commercial, 2018-2027

3.2 India Cell and Gene Therapy Market Size by Clinical, 2018-2027

4 India Cell and Gene Therapy Market Share by Product, 2018-2027

5 India Cell and Gene Therapy Market Share by Route of Administration, 2018-2027

5.1 India Cell and Gene Therapy Market Size by Injectables, 2018-2027

5.2 India Cell and Gene Therapy Market Size by Topicals, 2018-2027

5.3 India Cell and Gene Therapy Market Size by Infusions, 2018-2027

5.4 India Cell and Gene Therapy Market Size by Bioscaffolds, 2018-2027

6 India Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027

6.1 India Cell and Gene Therapy Market Size by Rare Diseases, 2018-2027

6.2 India Cell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027

7 India Cell and Gene Therapy Market Share by Type of Cell, 2018-2027

7.1 India Cell and Gene Therapy Market Size by CAR-T Cell, 2018-2027

7.2 India Cell and Gene Therapy Market Size by TCR Cell, 2018-2027

8 India Cell and Gene Therapy Market Share by Therapy, 2018-2027

8.1 India Cell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027

8.2 India Cell and Gene Therapy Market Size by NK Cell, 2018-2027

8.3 India Cell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027

8.4 India Cell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027

9 India Cell and Gene Therapy Market Share by Source of Cell, 2018-2027

9.1 India Cell and Gene Therapy Market Size by Autologous, 2018-2027

9.2 India Cell and Gene Therapy Market Size by Allogenic, 2018-2027

10 India Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027

10.1 India Cell and Gene Therapy Market Size by In-vivo, 2018-2027

10.2 India Cell and Gene Therapy Market Size by Ex-vivo, 2018-2027

11 India Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027

11.1 India Cell and Gene Therapy Market Size by In-House, 2018-2027

11.2 India Cell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027

12 India Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027

12.1 India Cell and Gene Therapy Market Size by Oncology, 2018-2027

12.2 India Cell and Gene Therapy Market Size by Neurology, 2018-2027

12.3 India Cell and Gene Therapy Market Size by Ophthalmology, 2018-2027

12.4 India Cell and Gene Therapy Market Size by Musculoskeletal, 2018-2027

12.5 India Cell and Gene Therapy Market Size by Others, 2018-2027

13 India Cell and Gene Therapy Market Share by Technology, 2018-2027

13.1 India Cell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027

13.2 India Cell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027

13.3 India Cell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027

13.4 India Cell and Gene Therapy Market Size by Others Technologies, 2018-2027

14 India Cell and Gene Therapy Market Share by End User, 2018-2027

14.1 India Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027

14.2 India Cell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027

14.3 India Cell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027

For more information about this report visit https://www.researchandmarkets.com/r/568hnb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900